Radiofrequency Ablation Devices Market For Pain Management, By Product [Equipment, Reusables (Probes, Electrodes), Disposables (Cannulas, Needles, RF-Single Use Probe, RF- Single Use Electrodes)], By Application (Cardiology, Oncology, Gynecology, Pain Man

Radiofrequency Ablation Devices Market For Pain Management, By Product [Equipment, Reusables (Probes, Electrodes), Disposables (Cannulas, Needles, RF-Single Use Probe, RF- Single Use Electrodes)], By Application (Cardiology, Oncology, Gynecology, Pain Management, and Others), By End User (Hospitals, Ambulatory Surgical Centers, and Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Radiofrequency Ablation (RFA) is a minimally invasive medical procedure involving the ablation of targeted dysfunctional tissues via the generation of heat from high frequency alternative current. It functions by converting electrical energy to heat energy and then utilizing the concepts of hyperthermia to burn the unwanted or affected tissue, leaving behind a scar which eventually heals in time.

RFA devices use an electrosurgical generator connected to bipolar electrode arrays to deliver thermal energy to tissue. Electricity travels through tissue between alternating positive and negative poles along the electrode arrays of the RFA device in the radiofrequency range of 450 to 500 kHz. RF ablation results in coagulative necrosis of tissue from high temperatures. The dipole molecules (mostly water) immediately next to the tip of the RF electrode attempt to remain aligned in the direction of the current and are forced to vibrate as rapidly as alternating current is applied.

Market Dynamics

The increasing organic growth strategies, such as product launches, by key market players to expand their product portfolios is expected to drive the market growth over the forecast period. For instance, in November 2020, Abbott, a healthcare company, announced the launch of IonicRF Generator, a new device to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous system. IonicRF Generator is a radiofrequency ablation device that uses heat to target specific nerves and block pain signals from reaching the brain. Radio frequency ablation has been used to treat pain, such as low back pain and Sacroiliac joint (buttocks) pain that fails to get resolved by conservative treatments such as physical therapy, injections, or medication.

Key features of the study:

• This report provides an in-depth analysis of the global radiofrequency ablation devices market for pain management and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global radiofrequency ablation devices market for pain management based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Boston Scientific Corporation, Accuray, Inc., Avanos Medical, Inc., Biosense Webster, Inc., Cosman Medical, Inc., Diros Technology, Inc., Kimberly-Clark Corporation, NeuroTherm, Inc., Stryker, AngioDynamics, Medtronic, Sutter Medizintechnik GmbH, Bramsys, Epimed International, sfm medical devices GmbH, Baylis Medical, AtriCure, Inc., ENDO-FLEX GmbH, and Hologic, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global radiofrequency ablation devices market for pain management report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radiofrequency ablation devices market for pain management

Detailed Segmentation:

• Global Radiofrequency Ablation Devices Market For Pain Management, By Product Type:
• Probes
• Electrodes
• Cannulas
• Needles, RF- Single Use Probe
• RF- Single Use Electrodes Forceps & Spatulas
• Equipment
• Reusables
• Disposables
• Global Radiofrequency Ablation Devices Market For Pain Management, By Application:
• Cardiology
• Oncology
• Gynecology
• Pain Management
• Others
• Global Radiofrequency Ablation Devices Market For Pain Management, By End User:
• Hospital
• Clinics
• Ambulatory Surgical Centers
• Others
• Global Radiofrequency Ablation Devices Market For Pain Management, By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
• Company Profiles
• Boston Scientific Corporation
• Accuray, Inc.
• Avanos Medical, Inc.
• Biosense Webster, Inc.
• Cosman Medical, Inc.
• Diros Technology, Inc.
• Kimberly-Clark Corporation
• NeuroTherm, Inc.
• Stryker
• AngioDynamics
• Medtronic
• Sutter Medizintechnik GmbH
• Bramsys
• Epimed International
• sfm medical devices GmbH
• Baylis Medical
• AtriCure, Inc.
• ENDO-FLEX GmbH
• Hologic, Inc.